Cannell & Co. - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 60 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.19 and the average weighting 1.8%.

Quarter-by-quarter ownership
Cannell & Co. ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$12,000
-29.4%
20,0000.0%0.00%
-100.0%
Q3 2019$17,000
+30.8%
20,0000.0%0.00%
Q2 2019$13,000
-18.8%
20,0000.0%0.00%
-100.0%
Q1 2019$16,000
-71.4%
20,000
-42.9%
0.00%
-50.0%
Q4 2018$56,000
-43.4%
35,000
+16.7%
0.00%
-50.0%
Q3 2018$99,000
+45.6%
30,0000.0%0.00%
+33.3%
Q2 2018$68,000
+134.5%
30,000
+200.0%
0.00%
+200.0%
Q1 2018$29,000
-90.6%
10,000
-90.9%
0.00%
-90.9%
Q4 2017$307,000
-23.4%
109,8750.0%0.01%
-21.4%
Q3 2017$401,000
+64.3%
109,8750.0%0.01%
+75.0%
Q2 2017$244,000
+360.4%
109,875
+22.9%
0.01%
+300.0%
Q1 2017$53,000
+10.4%
89,3750.0%0.00%0.0%
Q4 2016$48,000
-57.5%
89,375
-29.9%
0.00%
-50.0%
Q3 2016$113,000
-8.1%
127,5000.0%0.00%0.0%
Q2 2016$123,000
+5.1%
127,5000.0%0.00%0.0%
Q1 2016$117,000
-27.3%
127,5000.0%0.00%
-20.0%
Q4 2015$161,000
+4.5%
127,5000.0%0.01%0.0%
Q3 2015$154,000
-30.6%
127,5000.0%0.01%
-16.7%
Q2 2015$222,000
+29.8%
127,500
+8.3%
0.01%
+20.0%
Q1 2015$171,000
+72.7%
117,7000.0%0.01%
+66.7%
Q4 2014$99,000
-40.7%
117,700
-21.7%
0.00%
-40.0%
Q3 2014$167,000
-39.3%
150,4000.0%0.01%
-37.5%
Q2 2014$275,000
+22.2%
150,4000.0%0.01%
+14.3%
Q1 2014$225,000150,4000.01%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Greylock XI GP Limited Partnership 584,004$1,068,000100.00%
GREAT POINT PARTNERS LLC 2,325,000$4,255,0001.89%
Sarissa Capital Management LP 2,570,759$4,704,0001.60%
Deer VI & Co. LLC 675,242$1,236,0000.68%
Palo Alto Investors LP 1,200,800$2,197,0000.16%
Baupost Group 3,829,350$7,008,0000.11%
Gruss Capital Management LP 533,253$976,0000.05%
Granahan Investment Management 676,451$1,238,0000.04%
Fore Research & Management, LP 674,200$1,233,0000.04%
TFS CAPITAL LLC 210,369$385,0000.03%
View complete list of AVEO PHARMACEUTICALS INC shareholders